Underscoring these concerns, nearly half of insured adults (46%) say that lowering out-of-pocket costs is the change they'd most like to see to their health insurance.

Regeneron will provide Otarmeni — a new gene therapy for an ultra-rare form of genetic hearing loss recently approved by the U.S. Food and Drug Administration — for free under a new agreement with the U.S. government.

CenterWell Pharmacy (a part of Humana Inc.) announced plans to develop end-to-end employer prescription solutions with Cost Plus Drugs.

The new program seeks to connect GLP-1 management with primary care and Amazon Pharmacy in one place, according to the company.

A third (34%) of those laid off first heard the news through workplace gossip, more than those told directly by their manager or HR (27%).

Those who would consider returning would demand at least a 20% pay increase to make the switch.

Daily negative emotions among workers — including stress, anger or sadness — have declined since the pandemic, but they remain elevated.

Findings of the new Lockton 2026 National Benefits Survey indicate that 46% of self-funded plan sponsors say they would consider international drug sourcing for pharmacy benefits, an approach that remains complex and may expose plan sponsors to legal and compliance risks if not properly designed and administered.